US Patent 11850275 Liquid formulations comprising mutant FGF-21 peptide pegylated conjugates
Patent 11850275 was granted and assigned to 89Bio on December, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+13 properties)
Article (+314 characters)
US Patent 11850275 Liquid formulations comprising mutant FGF-21 peptide pegylated conjugates
Article
Patent abstract
The present disclosure relates to liquid pharmaceutical compositions comprising mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugate and prefilled syringe or autoinjector comprising liquid pharmaceutical compositions comprising mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugate.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Boris Schwartsburd0
Shaji Joseph0
Date of Patent
December 26, 2023
0Patent Application Number
181650810
Date Filed
February 6, 2023
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11850275 Liquid formulations comprising mutant FGF-21 peptide pegylated conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
